Clopidogrel Bisulfate/S-metoprolol

硫酸氢氯吡格雷/S-美托洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameClopidogrel Bisulfate/S-metoprolol

Drug Alias NameS-美托洛尔硫酸氢氯吡格雷Clopidogrel Bisulfate and S-metoprololS-metoprolol/Clopidogrel BisulfateS-美托洛尔/硫酸氢氯吡格雷S-metoprolol and Clopidogrel Bisulfate +[6]

ClassificationSmall molecules

Mechanisms of ActionPurinergic receptor P2Y12 antagonists

TargetsPurinergic receptor P2Y12

Therapy Area/IndicationsHypertensionThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Clopidogrel Bisulfate

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEmcure Pharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEmcure Pharma

Active IndicationsN/A

Inactive IndicationsHypertensionThrombosis

Other Information

ATC CodeN/A